CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bioject Medical Technologies Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bioject Medical Technologies Inc.
7180 SW Sandburg Street
Suite 100
Phone: (503) 692-8001p:503 692-8001 Tigard, OR  97223-8163  United States Fax: (503) 692-6698f:503 692-6698

On 4/5/2016, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Bioject Medical Technologies for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.

Business Summary
Bioject Medical Technologies, Inc. is engaged in the development of needle-free injection therapies. The Company's products include Biojector 2000 Needle Free Injection System, which is an injection system designed for healthcare providers; Bioject ZetaJet, which consists of a portable injector and an auto-disabling disposable syringe; Bioject Drug Reconstitution System, which has a connector that allows the user to withdraw medication from a vial without using a needle, and Needle-Free Vial Adapter, which is a non-sharp plastic device that replaces a fill needle for accessing medication vials making syringe filling completely needle-free. Its technology platform delivers a range of medications and vaccines to the subcutaneous, intramuscular and intradermal depths. It has developed a portfolio of injection systems based on its technology that includes durable devices designed for heavy use in a healthcare environment, and small and lightweight injectors designed for home use.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201412/31/2010YesYes--Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Chief Financial Officer, Secretary, Director Tony K.Chow 65 2/16/2015 7/1/2014
Executive Vice President, Chief Medical Officer, Member of Executive Committee Richard R.Stout 58 3/8/2007 3/8/2007
Director RalphMakar 2/15/2013 10/1/2007
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 33 (As of 12/31/2010)
Outstanding Shares: 18,908,594 (As of 9/30/2014)
Shareholders: 3,845
Stock Exchange: OTC
Federal Tax Id: 931099680
Fax Number: (503) 692-6698
Email Address: kmr@bioject.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023